Home
About the project
Partners
Events
Resources
News
Contact

News

Combining chemotherapy, immunotherapy and nanotechnology to treat cancer

6 IX 2016

Combining chemotherapy, immunotherapy and nanotechnology to treat cancer

Cancer treatment using nanotechnology tested with ‘astounding’ results
6 IX 2016
10 Breakthrough Technologies 2015 – MIT Technology Review
6 IX 2016
A Realistic Look at the Promises and Perils of Nanomedicine
6 IX 2016
Quantum Sensor Tracked in Human Cells Could Aid Drug Discovery
6 IX 2016
Researchers find brain’s ‘physics engine’
6 IX 2016

GEMNS Partners

GEMNS is granted in the European Union’s Seventh Framework Programme under frame of the ERA-NET EuroNanoMed2 (European Innovative Research and Technological Development Projects in Nanomedicine)

Projekt:

Realizacja:

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read More

Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT